Searched for
FDI IN PHARMA SECTOR
How India can win in a rewired global economyIndia is poised to gain from global supply chain shifts. Strategic neutrality and domestic focus are key. The nation must build robust buff...- India's productivity gap with China widens despite strong GDP growth; manufacturing leap still missing: ReportIndia's labour productivity gap with China has widened significantly since 2000, despite strong economic growth. The country has yet to ach...
- We expect interest rates to be left the way they are: Ficci chief Anant GoenkaFicci president Anant Goenka advocates for steady interest rates, citing supply-side price pressures from the West Asia crisis. He suggests...
- India-Oman CEPA kicks in June 1: What gets cheaper, which sectors gain, and key benefits explainedIndia's Comprehensive Economic Partnership Agreement with Oman comes into effect on June 1, granting New Delhi 100% duty-free access for 98...
- Govt has eased FDI norms for foreign cos having small Chinese/Hong Kong stake: An explainerIndia has eased Foreign Direct Investment rules for companies with up to ten percent Chinese or Hong Kong shareholding. These firms can now...
- Pharma sector to grow by 20 per cent on relaxed FDI norms: Ananth Kumar"The pharma industry is growing by 14 per cent every year. With relaxed FDI norms, I think pharma sector will grow by 20 per cent," Kumar s...
- Panel for blanket ban on FDI in brown field pharma unitsThe committee demands caution on the issue from the government and reiterates its recommendation to impose a blanket ban in FDI in brown fi...
- Non-compete clause for FDI in pharmaceutical companies will not be applicable: Reserve Bank of IndiaThe RBI today said the non-compete clause will not be applicable in acquisition of existing pharma cos by foreign entities except in specia...
- FDI in pharma doubled during April to DecemberThe government had cleared a Rs 5,168 crore proposal of US-based pharma firm Mylan Inc's to acquire Indian generic drugs company Agila Spec...
- FIPB to decide on GlaxoSmithKline, other pharma FDI proposalsFIPB will take up tomorrow GlaxoSmithKline's Rs 6,400 crore FDI plan, the largest foreign investment proposal in the pharma sector this fis...
- FDI in pharma sector jumps 86.5% during April-Oct periodFDI in drugs and pharmaceuticals was at $580 million during April-October 2012, according to the data of the Department of Industrial Polic...
- Welcome decision on FDI in pharma sectorIt is welcome that the Cabinet has shot down a proposal to restrict foreign direct investment (FDI) in the pharmaceutical sector.
- FDI in pharma sector doubled during April-AugustFaced with rush of multinationals to acquire Indian pharma firms, the Commerce and Industry Ministry is proposing to tighten the FDI policy...
- Cabinet to consider FDI liberalisation next week, says Anand SharmaThe Cabinet will take up the issue of relaxing FDI norms in about a dozen sectors next week, Commerce and Industry Minister Anand Sharma sa...
- Anand Sharma wants Prime Minister to convene meet to review FDI policy in pharmaCommerce Minister Anand Sharma has urged Prime Minister Manmohan Singh to convene a high-level review meeting to deliberate on the matter.
- FIPB clears seven pharma FDI proposal, defers threeThe FIPB discussed 30 Foreign Direct Investment (FDI) proposals, including 10 from pharma sector.
- Govt to finalise FDI policy in pharma before FIPB meetThe government is likely to finalise FDI policy with regard to existing drug companies ahead of the FIPB meeting on July 5.
- FDI in pharma sector faces fresh headwinds with DIPPDepartment of Industrial Policy and Promotion seeks review of the policy barely months after it was cleared at the intervention of the PM.
- Drugmakers ask government to allow FDI in pharma sectorThe change of heart comes ahead of the release of a report by the panel set up to study a proposal to reduce the FDI in pharma sector from ...
- Ministers' panel to look into FDI in pharma sectorThe immediate trigger for the move was the acquisition of Ahmedabad-based Paras Pharmaceuticals by British consumer goods and healthcare fi...
Load More
